First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Clinical trial NCT06797999 · RECRUITING

Trial details

NCT number: NCT06797999
Sponsor: Adcendo ApS
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Soft Tissue Sarcoma Unresectable Soft Tissue Sarcoma

Start date: 2025-06-05
Primary completion: 2029-02-27
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.